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ABSTRACT
Introduction: The primary purpose of this study is to
evaluate the relative effectiveness of 2 of the best
developed and most promising forms of therapy for
problem gambling, namely face-to-face motivational
interviewing (MI) combined with a self-instruction
booklet (W) and follow-up telephone booster sessions
(B; MI+W+B) and face-to-face cognitive–behavioural
therapy (CBT).
Methods and analysis: This project is a single-blind
pragmatic randomised clinical trial of 2 interventions,
with and without the addition of relapse-prevention text
messages. Trial assessments take place pretreatment,
at 3 and 12 months. A total of 300 participants will be
recruited through a community treatment agency that
provides services across New Zealand and randomised
to up to 10 face-to-face sessions of CBT or 1 face-to-
face session of MI+W+up to 5 B. Participants will also
be randomised to 9 months of postcare text
messaging. Eligibility criteria include a self-perception
of having a current gambling problem and a
willingness to participate in all components of the
study (eg, read workbook). The statistical analysis will
use an intent-to-treat approach. Primary outcome
measures are days spent gambling and amount of
money spent per day gambling in the prior month.
Secondary outcome measures include problem
gambling severity, gambling urges, gambling
cognitions, mood, alcohol, drug use, tobacco,
psychological distress, quality of life, health status and
direct and indirect costs associated with treatment.
Ethics and dissemination: The research methods to
be used in this study have been approved by the
Ministry of Health, Health and Disability Ethics
Committees (HDEC) 15/CEN/99. The investigators will
provide annual reports to the HDEC and report any
adverse events to this committee. Amendments will
also be submitted to this committee. The results of
this trial will be submitted for publication in peer-
reviewed journals and as a report to the funding body.
Additionally, the results will be presented at national
and international conferences.
Trial registration number: ACTRN12615000637549.
INTRODUCTION
Problem gambling and wider
gambling-related harms constitute a signiﬁ-
cant health and social problem in many
parts of the world.1 2 The New Zealand
National Gambling Study indicates that disor-
dered gambling contributes to, and is asso-
ciated with, a broad spectrum of morbidity
and harm to individuals, families and com-
munities.3 The 2011/2012 New Zealand
Health Survey found that problem gamblers
are nearly four times more likely to smoke
and almost ﬁve times more likely to engage
in hazardous alcohol consumption than non-
problem gamblers.4 People with problem
gambling have much higher rates of a
number of mental health conditions, particu-
larly substance misuse, affective and anxiety
disorders.5 6 These rates are typically higher
in help-seeking settings than in general
population studies.
Psychological treatment for problem gam-
bling includes various combinations of cogni-
tive–behavioural therapies (CBTs) and
motivational approaches such as motivational
Strengths and limitations of this study
▪ As a pragmatic trial, this study can determine
the effectiveness of cognitive–behavioural and
motivational treatments for problem gambling
when delivered in a community setting.
▪ The proposed sample size will permit subgroup
analyses of a range of potential mediators and
moderators.
▪ The study examines the use of text messaging
as a method of extending treatment and prevent-
ing relapse.
▪ Recruitment within one large clinical setting may
have an impact on speed of participant
recruitment.
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interviewing (MI). These treatments have
moderate-to-high effect size (ES) and are better than
no-treatment controls.7 8 A recent study by Battersby and
colleagues9 combined cognitive restructuring10 11 and
graded exposure with response prevention. This pro-
gramme is designed to be ﬂexible, beneﬁt from syner-
gies between the behavioural and cognitive elements
and enhance treatment adherence.
MI has attracted less research attention than CBT. A
Cochrane review identiﬁed just four studies involving MI
(out of a possible 14) and concluded that MI may have a
positive impact on gambling behaviour, but there was
insufﬁcient evidence of it having an effect on other gam-
bling impacts (eg, depression or anxiety).8 The review
focused on studies involving clients presenting to
face-to-face services and did not take into account studies
involving telephone or online administration.12–14 When
delivered with other resources or support, such as a
behavioural and cognitive strategies workbook or add-
itional post-treatment support sessions, MI results in a sig-
niﬁcant reduction in gambling behaviour that is
sustained over a longer time period.15 A recent telephone
trial reported that MI plus a workbook plus booster tele-
phone sessions (MI+W+B) resulted in signiﬁcantly better
outcomes for Māori (New Zealand’s indigenous popula-
tion), people with more severe gambling problems,
higher comorbidity and those who sought to moderate
rather than stop gambling.16
There are few efﬁcacy, effectiveness or outcome
studies that have examined the longer term durability of
treatment effects. Cochrane and other reviews have
noted that these interventions are ‘possibly efﬁcacious’
because no intervention has been demonstrated to meet
formal efﬁcacy or effectiveness standards. In addition,
there are very few studies that have evaluated longer
term outcomes or developed or assessed ways to sustain
treatment effects and prevent relapse. A number of
studies have failed to demonstrate outcome differences
between different types and intensities of treatment for
problem gambling.16–19 How much of this is a conse-
quence of a lack of statistical power and other design
deﬁciencies rather than lack of difference in therapeutic
potency is unclear.
Prospective general population studies indicate that for
most people problem gambling has a ﬂuctuating natural
history, with many people transitioning into and out of
problem states of varying severity and duration.3 20 While
natural recovery rates appear to be high, greater problem
severity and comorbidity are associated with chronicity
and relapse.21 This highlights the importance of develop-
ing interventions that maintain treatment outcomes and
reduce the frequency of relapse. Text messaging has been
posited as an easy method of extending treatments and
reducing relapse and has been associated with positive
outcomes in tobacco, but less so for a study involving a
small sample size and alcohol misuse.22–25 A recent study
offered 12 change strategies over a 12-week period to
gamblers accessing online counselling (ie, a single
session of chat, email, community forums or very brief
self-help).26 This study reported that text messages did
not lead to greater improvement in gambling symptoms
or behaviour over and above the online treatment
accessed. These ﬁndings were possibly due to a small
sample size, frequency of messages and lack of message
tailoring (ie, to their readiness to change).
There is an urgent need to determine the most effect-
ive treatments for gambling disorder and also determine
how they can be widely adopted in practice settings. The
current study is designed to address the shortcomings in
the research base underlying treatment for problem
gambling. Shortcomings include a small sample size
leading to low statistical power, heterogeneous samples,
high attrition, inadequate follow-up, lack of protocol
driven treatments, missing or skewed data, single site
clinical trials, failure to include comparative or control
groups and intention-to-treat (ITT) analyses, lack of
study replication by independent investigators and high
rates of non-speciﬁc treatment response. It will extend
research by taking promising interventions that have
been examined in efﬁcacy studies with predominantly
non-clinical volunteers and evaluating them in clinical
settings. Moreover, the study will determine effectiveness
and involve community-based counsellors and clients
seeking help from gambling counselling services.
The primary aim of this trial is to evaluate the relative
effectiveness of two of the best developed and most prom-
ising forms of therapy for problem gambling, namely
face-to-face MI+W+B and face-to-face CBT. Secondary
aims of this study are to evaluate the effectiveness of
gambling-related post-treatment text messaging in pre-
venting relapse and sustaining treatment gains at
12 months and evaluate the extent to which common
comorbidities diminish following therapy. In addition,
engagement will be the potential moderator and medi-
ator. The study will also identify which, if any, of the inter-
ventions is more effective for a variety of client ethnic
groups including Māori and Paciﬁc, and groups identi-
ﬁed by problem severity and comorbidities. Additionally,
it will identify the relationship between changes in poten-
tial mediators of treatment response including comorbid-
ities and reductions in gambling participation and
problems. The primary hypothesis is that CBT partici-
pants will show greater clinically meaningful reductions
in gambling and problem gambling than MI+W+B parti-
cipants at 12 months. Secondary hypotheses are:
▸ CBT and MI+W+B will be equivalent with respect to
reductions in gambling and problem gambling at
3 months;
▸ Participants allocated to the post-treatment text mes-
saging conditions, in the CBT and MI+W+B groups,
will show greater clinically meaningful reductions in
gambling and problem gambling at 12 months than
those in the non-text messaging condition;
▸ CBT participants will have greater reductions in
depression and anxiety than MI+W+B participants at
12 months.




We will conduct a single-blind pragmatic randomised
clinical trial (RCT) of two interventions, with and
without the addition of text messages, and with a pro-
spective follow-up. Trial assessments take place pretreat-
ment, at 3 and 12 months. Therapy interventions, namely
face-to-face CBT and a single face-to-face MI+W+ 5 B, will
be conducted over 3 months. Following the 3-month
assessments, participants receiving CBT and MI+W+B
who are allocated to the text conditions will receive text
messaging for 9 months. Primary outcome measures will
be days gambled (self-reported number of days gambled
in the previous month) and money spent (self-reported
money spent per day in the previous month). These out-
comes will be treated as a multivariate outcome in the
analysis. The research methods to be used in this study
have been approved by the Ministry of Health, Health
and Disability Ethics Committees (HDEC) 15/CEN/99.
Participants and recruitment
Participants will be recruited from people seeking help
from the Salvation Army Addiction Services—Gambling
(Oasis) for problems with their own gambling. Oasis is a
national problem gambling service provider operated by
the Salvation Army that provides services to all major
ethnicities in New Zealand. Gamblers who contact Oasis
centres for treatment will be informed of the trial by the
administrator or counsellor with whom they have made
initial contact.
Individuals are eligible to participate if they are a
minimum age of 18 years; self-perception of having a
current gambling problem; willing to read materials
related to the study (to ensure reading ability); willing to
participate in counselling and other treatment compo-
nents; willing to have counselling sessions recorded and
willing to provide follow-up data on gambling.
Participants will also be asked to provide the details of a
collateral person (family member or friend) for the pur-
poses of follow-up (staying in touch when contact details
change) and as a check on gambling information pro-
vided. Participants will not be precluded from taking
part in the study if they are not comfortable giving the
details of collateral persons. Exclusion criteria will be
the presence of active psychosis or active suicidal intent
which is routinely assessed at intake at the clinician’s dis-
cretion. See ﬁgure 1 for the study ﬂow chart.
Clients who meet the eligibility criteria and give their
verbal consent to participate will be contacted by a
trained research assistant who will administer the base-
line assessment questionnaire. Screening details
required by Oasis and the treatment allocation informa-
tion will be transferred to Oasis ahead of the client’s
scheduled appointment. Assessment interviews will be
conducted by a research assistant within 7 days from the
client’s initial contact with the service.
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Randomisation
To ensure equal numbers across the four conditions,
block randomisation will be used, with random block
sizes varying between 4 and 12 to promote concealment.
The block size distribution will be kept secret until the
unblinding. Block randomisation will be stratiﬁed on
recruitment site and self-declared ethnicity deﬁned on
three levels: Māori, Paciﬁc and others. The randomisa-
tion schedule algorithm will be coded by information
technology staff (supervised by the trial statistician) and
implemented by an independent party who will select a
seed for the pseudorandom number generator and gen-
erate the actual schedule. Participants will be allocated
to one of the four treatment combinations in a 1:1:1:1
ratio (CBT or MI+W+B plus text messaging, CBT or MI
+W+B without text messaging).
Intervention conditions
Motivational interviewing plus self-help workbook and
telephone follow-up
MI+W+B will integrate a single face-to-face motivational
interview, a self-help workbook and ﬁve follow-up motiv-
ational telephone sessions. The ﬁrst of these follow-up
sessions may be delivered face to face rather than by
telephone if strongly preferred by the participant. MI
will be structured to encourage clients to build a com-
mitment to change by emphasising the reasons why
change is desirable and has been previously described
by Abbott et al.16 The self-help workbook was evaluated
in a previous New Zealand trial involving helpline
callers16 and this was based on a resource that has been
evaluated multiple times.12 14 The telephone sessions
will focus on motivation of, and reinforcement for,
behaviour change through the use of the workbook.
They will be offered for 10–50 min duration at ∼1, 2, 4,
8 and 12 weeks.
Cognitive–behavioural therapy
The CBT intervention will be up to 10 face-to-face ses-
sions offered for up to 90 min each session over a
12-week period. Therapy is based on a manual that
Battersby and colleagues have developed drawing on
behavioural therapy and cognitive therapy. Though the
protocol is sequential, the manual allows therapists some
ﬂexibility with session sequencing, dependent on client
response and progress. The intervention is informed by
the outcomes of a pilot RCT and previous clinical
trials11 17 and trialled with 41 state-wide gambling service
treatment patients in Australia. As described in table 1, it
incorporates imaginal and real-life cue exposure to gam-
bling triggers and habituation/urge extinction. It also
includes interventions directed towards understanding
randomness and erroneous beliefs, awareness of inaccur-
ate perceptions, and cognitive correction to erroneous
perceptions. Regular homework sessions will also take
place, focusing both on behavioural and cognitive goals,
and recorded in diaries. This will be discussed in
face-to-face sessions and progress reinforced.
Table 1 Components of the cognitive–behavioural therapy arm (10 sessions)
Topic Indicative content
1. Screening and assessment Main problem is identified and suitability for treatment determined.
Rationale for exposure therapy and cognitive therapy is provided.
2. Problem identification and goals A psychosocial history is completed, including past psychiatric history and
developmental history.
Measurable problem and goal statements are developed and exposure therapy is
introduced.
3. Psychoeducation Client is introduced to a series of activities to differentiate games of skill from games
of chance. Independence of events is demonstrated and the concept of illusions of
control introduced.
4. Exposure task Review of completed cue exposure task. Problem solving and continuing graded
exposure task activities
5 Exposure task and cognitive
awareness
Continuing graded exposure tasks. ABCD model is introduced as well as the
concept of automatic thoughts and cognitive distortions
6–9 Exposure task and cognitive
restructuring
Review of completed cue exposure tasks and continuing graded exposure tasks.
Identification and restructuring of unhelpful cognitions through application of the
ABCD model
Behavioural experiments may be introduced to test beliefs where appropriate. These
will be carefully designed as to not expose the client to increased risk of gambling
and will preferably be counsellor led in the first instance (in vivo).
10. Problem solving (optional) and
relapse prevention
Introduction to a formal problem-solving technique and to the concepts of ‘slips’ and
‘relapse’. Clients are helped to develop a relapse prevention plan through the
identification of early warning signs, identification of useful strategies and planning
to ask for help in need.
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Text messaging
Participants allocated to the text-messaging component
will receive an average of two text messages per week
from the 3-month assessment until the 12-month assess-
ment. Messages were derived from a study investigating
the helpfulness and uptake of 99 change strategies used
by gamblers to limit or control their gambling.27 The
most frequent and helpful change strategies for those
who were actively attempting to change (classiﬁed as
action state of change) as well as up to 2 years postrecov-
ery (maintenance) were identiﬁed and ranked accord-
ing to the most helpful and most frequently used. Six
change strategies and 56 actions were identiﬁed includ-
ing planning, delay, connecting with others, engaging
with alternative activities, cognitive strategies and well-
being (see table 2 for a full list).
Messages were examined for readability and relevance
with a consumer, four counsellors and an experienced
team leader. The language of eight items was amended,
an item on self-exclusion was deleted (it was assumed to
have already been undertaken) and a reminder to
recontact services was added to the cognitive condition.
Messages were also developed that were tailored to the
treatment condition. MI participants will receive mes-
sages that encourage self-reﬂection on treatment goals
and workbook use. CBT participants will receive encour-
agement for using cognitive and behavioural strategies.
Messages will be personalised and also start with the
wording “some people ﬁnd this helpful to…” which will
take into account that participants may already have
implemented the change strategy.
Therapists
This study was conceptualised as a pragmatic trial to
determine the effectiveness of these treatments in real-
life settings. For this reason, all experienced therapists
from the Oasis treatment services will be trained to
deliver MI and CBT treatments. To remove potential
contamination of the RCT design by therapist effects,
therapists will deliver both treatments. Prior to starting
work on the trial, therapists will receive a minimum of
7 days training over three blocks of time. Training will be
provided by investigators MB (CBT) and DCH (MI+W
+B) who developed the interventions and are inter-
national experts in their ﬁeld. Ongoing supervision by
trained and experienced clinical psychologists will be
provided to ensure consistency in the delivery of both
interventions. A key advantage of this study is that all
therapists offer both interventions. Any bias due to ther-
apist effects (where more or less skilled therapists are
associated with one treatment) is minimised. This poten-
tial confound will also be reduced by involving multiple
counsellors across a number of sites as well as extensive
ﬁdelity checks that treatment is being delivered as per
protocol. Sessions will be recorded and protocols for
assessing treatment ﬁdelity applied and one-third of the
ﬁdelity checkers reports being double checked for inter-
rater reliability and ﬁdelity. For MI+W+B, recordings will
be coded based on the Motivational Interviewing
Treatment Integrity (MITI) scale28 and for the CBT
intervention a competence checklist used in the pilot
RCT will be administered.29
Baseline assessment
Baseline measures will be administered by trained
research assistants and the data will be directly entered
into an in-house built database developed speciﬁcally for
this RCT. Baseline assessment will involve brief demo-
graphics (age, gender, ethnicity, marital status, living
arrangements, employment, education, income), the
eight-item New Zealand Index of Socioeconomic
Deprivation for Individuals,30 gambling impacts (ie,
work, social life, family and physical health)31 and past
help seeking. A brief gambling history will be obtained
including length of gambling problem, type/s of gam-
bling causing problems, number, nature and outcomes
of past attempts to quit or reduce gambling and past
treatment and mutual help involvement. Participants
will be asked to nominate a goal: stop all forms of gam-
bling, stop only problematic forms of gambling, or
reduce their gambling habits. Belief in likelihood of
achieving treatment goal, motivation for goal and sense
of control over gambling will be measured with a readi-
ness ruler (0 ‘not at all conﬁdent’ to 10 ‘extremely conﬁ-
dent’; ‘no control’ to ‘total control’). Primary outcomes
of days spent gambling and amount of money spent per
day gambling will be measured over the previous
2 months using the timeline follow back procedure.32
Pretreatment scores will be calculated, averaged over the
2 months prior to entry. Problem gambling will be deter-
mined by the Problem Gambling Severity Index
(PGSI),33 with categories corresponding to 0=no risk; 1–
2=low risk; 3–7=moderate risk; 8–27=problem gambler.
The primary outcome for the follow-up study at
12 months will be the dichotomised indicator of
problem gambler (PGSI 8–27) versus no risk to moder-
ate risk (PGSI<8).
Other gambling measures include the Gambling Urge
Scale (GUS)34 where higher scores indicate greater
urges to gamble with a range 0–42. The GUS has
demonstrated concurrent, predictive and criterion valid-
ity among non-clinical gamblers and has also been used
successfully in clinical samples.35 Gambling-related cog-
nitions will be measured with the Gambling Related
Cognitions Scale (GRCS) which is a 23-item seven-point
Likert scale that records the degree of agreement with
common thoughts associated with gambling disorder.36
The mood and alcohol modules of the Primary Care
Evaluation of the Mental Disorders (PRIME-MD)37 will
be administered to provide diagnoses of major depres-
sive disorder, dysthymia, minor depressive disorder and
alcohol abuse/dependence. This is a structured inter-
view designed for primary care clinicians and research-
ers to diagnose these and other current Diagnostic and
Statistical Manual of Mental Disorders (DSM) mental
health disorders. It has been validated against the
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Table 2 Text messages for MI and CBT groups*
Message content
Stage 1: CBT arm
specific
Some people find it helpful to complete an automatic thought diary exercise in their exercise book if
they notice any gambling related thoughts. Txt STOP to opt out of these messages.
Nip gambling urges in the bud and revisit some of their exposure tasks or the gambling cycle in
their exercise book to see if they can identify the trigger.
Remember that if they experience an urge to gamble, it will eventually subside by itself without
gambling. Sit with it and allow it to pass.
Limit access to cash when performing new exposure tasks, particularly during early stages of the
exposure programme. This will allow you to grade it appropriately.
Remember that the more you put in the more you will get out, so try and do a task from the
exercise book every day.
Remember that repeated habituation through performing exposure tasks will eventually lead to
conquering gambling urges.
Remember that lapses or ‘bumps’ are no big deal.
Remember that repeated habituation will eventually lead to extinction. Allowing yourself to
experience your urge by focusing on it without gambling is called habituation.
Ask what is the evidence for and against this thought if they notice a thought that tempts them to
gamble. Are you jumping to conclusions without looking at all the facts?
Remember the difference between games of skill and games of chance. In games of chance, there
is nothing you can do to influence or predict the outcome.
Stage 1: MI arm specific Some people find it helpful to re-read sections of the Becoming a Winner: Defeating Problem
Gambling self-help workbook you received. Txt STOP to opt out of these messages.
Read the section on Dealing with Urges in the Becoming a Winner workbook.
Remind themselves periodically about the benefits and costs of gambling described in the
Becoming a Winner workbook.
Think again about the ideas provided in Becoming a Winner for limiting access to money.
Consider whether there are other life issues that they should address (see Becoming a Winner).
Review and revise their plan for dealing with slips that they made in Becoming a Winner.
Motivating to share their personal gambling goals with other people (Becoming a Winner).
Remind themselves of some of the consequences of their gambling that they listed in Becoming a
Winner.
Think about where they would like to be in life in 5 years and whether gambling might interfere with
this.
Re-read how they responded to the questions they completed in the Becoming a Winner workbook.
Stage 1: plan and delay Take it easy on yourself or take it slow.
Distract yourself or do something else until the urge to gamble passes.
Postpone gambling until a later date to allow the urge to pass.
Avoid gambling when feeling down, depressed or otherwise vulnerable.
Avoid the first bet because the urge will pass soon enough.
Do things that are incompatible with gambling like meeting a friend, taking a walk without cash or
having an early night.
Plan ahead—leave credit cards and non-essential cash at home.
Keep busy to avoid thinking about or engaging in gambling.
Be ready to implement your own personal strategies to deal with gambling triggers.
Count days since you have made a change in your gambling.
Keep track of money by setting up a budget and tracking spending.
Plan ahead and limit the amount of money you carry.
Plan to spend more time with other people.
Stage 2: cognitive Think about how your money could be better spent.
Remain hopeful about your future.
Remind yourself that you do not need to gamble.
Re-establish trust and belief in yourself.
Make a resolution to continue changing your gambling.
Make a daily affirmation such as staying positive or letting go.
Focus on not gambling each day at a time.
Concentrate on being strong or using will power.
Monitor how your emotions relate to gambling.
Monitor for signs that gambling is becoming a problem again.
Recontact your counsellor or peer support if a check-in could be helpful.
Focus on regaining trust with family and friends.
Continue to accept that you had a problem and move beyond testing yourself.
Continued
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Structured Clinical Interview for the DSM-IV.38 The use
of psychotropic medication and history of manic epi-
sodes will be assessed using questions modiﬁed from the
PRIME-MD37 and previously administered in the
Gambling Impact Study.39 A brief version of the 10-item
Drug Abuse Screening Test (DAST)40 will be adminis-
tered as well as questions about lifetime and current
tobacco use and any previous success at quitting
problem behaviour (smoking, alcohol, other drugs or
other behaviour).
The Kessler 10 (K10)41 questionnaire will be included
to provide a continuous measure of general psycho-
logical distress that is responsive to change over time.
Quality of life will be assessed by the EUROHIS-QOL
8-Item Index,42 an eight-item version of a widely used
measure. Health status will be assessed by the EuroQol
EQ-5D-5L,43 a ﬁve-item measure across the domain of
living (ie, mobility, self-care, usual activity, pain/discom-
fort and anxiety/depression). Self-reported data on
direct and indirect costs are associated with productivity
losses (eg, days off work) and out-of-pocket expenses
such as amount of money spent on gambling and trans-
portation costs.
Follow-up assessments
Trained research assistants blinded to the client inter-
vention will administer measures at 3 and 12 months. At
each follow-up assessment, days gambled and money
spent will be assessed with a timeline follow-back inter-
view. Post-treatment scores will be calculated for the
month following entry into the trial, in the period from
1 to 3 months and in the interval from 3 to 12 months.
Rulers (on a scale of 1–10) will be administered to deter-
mine the degree that treatment goals were met (not at
all, partially, mostly, completely) and also the sense of
control over gambling. Other screens readministered
will include PGSI, gambling impacts31 GUS, GRCS,
PRIME-MD, K10, EUROHIS-QOL 8-Item Index, current
tobacco use and cost-effectiveness questions. Participants
will also indicate whether they have sought other treat-
ment for gambling, tobacco smoking, alcohol, other
drugs or other behaviour. Information on workbook
Table 2 Continued
Message content
Stage 2: connect and
engage
Tell a trusted friend or family member about the extent of your gambling.
Be more open and honest with family and friends about gambling.
Ask family or friends to help or support you.
Engage in an activity that gives you a feeling of achievement.
Participate in regular structured groups or sports like football or tennis.
Engage in a new form of entertainment.
Explore additional work or study-related activities.
Listen, play, sing or dance to music.
Complete daily activities around the house.
Start a new hobby like arts, crafts or knitting.
Plan a reward or something to look forward to.
Taking a long walk can feel good as well as provide a chance to clear your head.
Practise relaxation strategies like yoga, meditation or mindfulness.
Stage 3: cognitive Remember that if you are triggered by feeling sad, lonely, angry, hungry or tired, gambling is not
the best option.
Monitor your progress. Have you had a change in the urge to gamble?
Calculate your time and money spent gambling: this can really help put it into perspective.
Keep a budget of your spending. This can help you to stay honest.
Acknowledge when you are feeling flat or lonely. This can make you think twice about gambling.
Tell yourself how much better off you will be: healthier, wiser and with more money.
Reflect on differences since changing your gambling: when someone asks to go to the movies, it is
nice to be able to say yes and not ‘no I am broke’.
Save for a reward like a holiday or a dinner out.
Think about the types of things that you could spend your money on.
Make a goal sheet and then mark off your achievements.
Stage 3: well-being Ensure your physical health needs are met.
Set up and regularly contribute towards a savings plan.
Eat a healthy balanced diet that makes you feel good.
Focus on managing issues that contribute to your gambling.
Learn to forgive yourself for past actions and focus on the future: tomorrow is what you can
change, not yesterday.
Be mindful of increasing fluid intake.
Engage in regular exercise.
*Each message started with “some people find this helpful…”.
CBT, cognitive–behavioural therapy; MI, motivational interviewing.
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engagement will also be collected (whether it had been
read, procedures followed, strategies used as well as most
and least helpful content) as well as the usefulness of
text messaging at 12 months.
After the 3 and 12 months assessments, at least one
collateral person per participant (when provided) will
be contacted by telephone and asked about the partici-
pant’s involvement with gambling over the past month.
They will also be asked whether he/she gambled notice-
ably less, at about the same level, or noticeably more
than in the past assessment period, and how conﬁdent
they are about the accuracy of their reports (not at all,
somewhat, fairly, extremely). Agreement between collat-
eral and participant reports on days gambled and
amount of money spent in the past month will subse-
quently be assessed using interclass correlation coefﬁ-
cients. Participants who decide to withdraw from the
trial, either during the period of intervention delivery or
at some point in the subsequent year, will be asked
(either by their counsellor or by an AUT research assist-
ant) if they could provide some information as to why
they have chosen to withdraw. Any adverse outcomes are
likely to be limited to emotional/psychological distress
by the participants during the assessment and/or
follow-up interviews. In such situations, the researchers
will terminate the interview and suggest that participants
contact their counsellor at Oasis or the Gambling
Helpline, or will offer to contact a service on their
behalf to arrange a call back.
Blinding
Participants will be aware of the trial arm they are
assigned to, although neither arm will be described to
participants as superior. Researchers blind to partici-
pants’ treatment groups will conduct baseline and
follow-up assessments.
Statistical analysis
Baseline covariate and outcome values will be tabulated
according to treatment groups, along with pooled SDs
for continuous outcomes. Missingness and attrition will
be reported by treatment group. Unadjusted results per
treatment group (CBT vs MI+W+B, text messaging vs
none, and full 2×2 factorial breakdown) will be pre-
sented with SEs. Should non-normality of residuals be
evinced (based on graphical assessment and standard
tests), alternative exponential family models with identity
link will be preferred to any change in the link function,
to avoid effect attenuation associated with averaging over
the link, typical of generalised estimating equation
(GEE) regression.
The primary analysis set will be the ITT analysis set,
comprising all participants, with their original treatment
allocation. All planned efﬁcacy analyses will be carried
out in the ITT set.
The primary outcomes will be regressed simultan-
eously in a multivariate model. Measurements at 3 and
12 months will be included in the model to improve
statistical efﬁciency. The primary and secondary hypoth-
eses will be tested and relevant contrasts, including treat-
ment effect differences at 12 months for each outcome,
estimated from regression models ﬁtted using GEEs to
regress the outcome measurements on the CBT/MI
intervention factor and the text messaging intervention
factor, adjusting for baseline value of the respective out-
comes. Primary inference will focus on detecting treat-
ment effects severally in each primary outcome,
applying false discovery rate control at the nominal 5%
level.44 A secondary inference will consist in producing
the observed signiﬁcance level for the treatment effect
on both primary outcomes simultaneously using an
F-test or equivalent.
Survival analysis of withdrawal will be applied to iden-
tify any prerandomisation and postrandomisation with-
drawal predictors. Missing outcome and baseline data
will be multiply imputed using prerandomisation and
postrandomisation outcome information and withdrawal
predictors,45 treatment assignment,46 and demographic
and other baseline covariates, under an assumption of
missingness at random.47 Ten imputed data sets will be
generated using a full conditional speciﬁcation48 on
these variables, although this number may be revised
after a blind review of the data.
Only two subgroups will undergo a planned efﬁcacy
analysis: Māori participants and Paciﬁc participants. For
this purpose, ethnicity will be prioritised. Subgroup ana-
lyses will be carried out using interaction of treatment
with subgroup identiﬁers. The primary purpose of the
analysis is to identify the presence of an effect in the
subgroup rather than test subgroup heterogeneity.
Mediation analyses will take place on primary and
selected secondary outcomes, the latter including
problem gambling severity and measures of substance
abuse. Mediation analyses will be carried out using
multivariate regression analyses involving both direct
pathways between intervention arm and outcome, and
similar but indirect pathways mediated by participation
measures.49
Sample size justification
In accordance with the primary inference, we base the
sample size justiﬁcation on an actual signiﬁcance level of
2.5%, which will yield a conservative sample size in
regard to false discovery rate control. We do not account
for the gain in efﬁciency inherent in modelling data at 3
and 12 months, also a conservative simpliﬁcation. We
will account for observed correlations with baseline
values, for which we will make an adjustment of 0.04 in
days gambled and 0.49 in money spent.16 We plan to
recruit a sample of 300 participants and expect to
reassess 270 (90%) at 3 months and 225 (75%) at
12 months. These estimates are based on the New
Zealand telephone RCT where retention was 88% at
3 months, 70% at 12 months and around 50% at
36 months. The trial sample size (targeted recruitment
of 300 yielding 225 complete assessments at 12 months;
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112 per treatment) is sufﬁcient to detect a difference at
12 months between two arms of 1.7 gambling days per
month (ES 0.25) and $7.90 per day in money spent (ES
0.13) with 80% power in the primary analysis. Assuming
participant proportions of 40% for Māori and 12% for
Paciﬁc people (based on expected percentage of people
accessing the Oasis service), and accounting for these
two subgroups in terms of testing multiplicity, we will be
able to detect a difference of 2.2 days (ES 0.32) and
$12.50 (ES 0.2) in Māori, and of 3.2 days (ES 0.46) and
$20 (ES 0.32) in Paciﬁc people with 80% power.
Data management
Screening details required by Oasis and the treatment
allocation information will be accessed by counsellors
from the secure online database hosted at AUT ahead of
the client’s scheduled appointment. Prior to starting
treatment, clients will give additional written consent for
their participation in the clinical trial. No identifying
personal information will be included in the reporting
of information gathered as part of this clinical trial. All
participant data will be aggregated prior to being
reported. Digital data will be stored only on modern
cryptographically strong password-protected and limited
access computer systems at the research ofﬁce. At con-
clusion of the project, an anonymised version of the
data set is available to external parties via the Ministry of
Health funding body.
Data monitoring
An independent Data Monitoring Committee (DMC)
will be established by the Steering Committee, com-
posed minimally of a biostatistician, a psychologist and a
data manager, none of whom are involved with the
study. The DMC Charter will be drawn by the study
Steering Committee and deﬁne the DMC mandate as
consisting of the following duties: monitoring data
quality, monitoring attrition, monitoring adverse events
and advising the Steering Committee as to trial conduct.
There are no formal interim analyses planned, as it is
not expected that adverse events will be differentially
causally related to the interventions.
DISCUSSION
To the best of our knowledge, this is the ﬁrst large-scale
trial that will compare the effectiveness of two well-
developed treatment approaches as well as postcare text
messaging. A strength of this study is its delivery in a
community treatment setting. Therapists from commu-
nity agencies will deliver both of the interventions, and
through this study have access to training and supervi-
sion in these treatments. However, this approach
increases the risk that there will be therapy leakage redu-
cing the differentiation between the interventions. To
address this issue, we have invested in extensive training
and ongoing supervision as well as extensive ﬁdelity
checks with the use of validated tools.
This study addresses many of the limitations present in
previous gambling treatment research including issues
associated with small sample sizes, heterogeneous samples
and single site clinical trials. This study does not include a
wait-list control because it would not be ethical to include
a wait-list control group in a study involving treatment
seekers recruited from a community agency. However, the
two interventions have been evaluated previously in efﬁ-
cacy trials that included wait-list controls. Working with a
large treatment agency is an important strength of this
study; however, it does pose some risks in terms of rate of
recruitment. In New Zealand, the gambling service system
has undergone some changes in the past 2–3 years,
including the establishment of a single national telehealth
centre that encompasses almost all helpline services for
mental health and addiction. Maintaining a ﬂow of clients
into the study relies on current numbers of clients being
referred to Oasis. It is our preference to maintain the
current protocol as we believe recruitment through one
large multisite setting strengthens this study, but other
recruitment options will be explored if required.
Minimising attrition in follow-up assessments is vital to
ensure the success of this trial. The at-risk and transient
nature of the target population makes this task more difﬁ-
cult. To mitigate this, participants will provide a collateral
person who can be contacted.
Despite these limitations, this trial has the potential to
make a signiﬁcant contribution in terms of addressing
problem gambling and improving the lives of people
impacted by this disorder. It has the potential to provide
people with problem gambling access to better treat-
ment. This research also aims to extend current knowl-
edge and inform policy and practice which can lead to
more cost-effective outcomes as well as a reduction in
gambling harms. Cultural considerations are also of
importance given the higher risk among Māori and
Paciﬁc people to develop problem gambling.
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